1. Tennant PW, Pearce MS, Bythell M, Rankin J.

20-year survival of children born with congenital

anomalies:
a population-based study. Lancet 2010; 375:649.
2. Bird TM, Hobbs CA, Cleves MA, et al. National rates of birth defects among hospitalized
newborns. Birth
Defects Res A Clin Mol Teratol 2006; 76:762.
3. Canfield MA, Honein MA, Yuskiv N, et al. National estimates and race/ethnic-specific variation
of selected
birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 2006; 76:747.
4. Talner CN. Report of the New England Regional Infant Cardiac Program, by Donald C. Fyler,
MD,
Pediatrics, 1980;65(suppl):375-461. Pediatrics 1998; 102:258.
5. Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal
cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed 2008; 93:F33.
6. Gregory J, Emslie A, Wyllie J, Wren C. Examination for cardiac malformations at six weeks of
age. Arch
Dis Child Fetal Neonatal Ed 1999; 80:F46.
7. Samnek M, Slavk Z, Zborilov B, et al. Prevalence, treatment, and outcome of heart disease
in live-born
children: a prospective analysis of 91,823 live-born children. Pediatr Cardiol 1989; 10:205.
8. Kuehl KS, Loffredo CA, Ferencz C. Failure to diagnose congenital heart disease in infancy.
Pediatrics
1999; 103:743.
9. Wu MH, Chen HC, Lu CW, et al. Prevalence of congenital heart disease at live birth in Taiwan.
J Pediatr
2010; 156:782.
10. Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth.
The Baltimore-
Washington Infant Study. Am J Epidemiol 1985; 121:31.
11. Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm infants.
Pediatrics 2005;
116:e833.
12. Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in
metropolitan
Atlanta, 1998-2005. J Pediatr 2008; 153:807.
13. Wren C, Irving CA, Griffiths JA, et al. Mortality in infants with cardiovascular malformations.
Eur J Pediatr
2012; 171:281.
14. Ishikawa T, Iwashima S, Ohishi A, et al. Prevalence of congenital heart disease assessed by
echocardiography in 2067 consecutive newborns. Acta Paediatr 2011; 100:e55.
15. Khoshnood B, Lelong N, Houyel L, et al. Prevalence, timing of diagnosis and mortality of
newborns with
congenital heart defects: a population-based study. Heart 2012; 98:1667.
16. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;
39:1890.
17. yen N, Poulsen G, Boyd HA, et al. Recurrence of congenital heart defects in families.
Circulation 2009;
120:295.
18. Liu S, Joseph KS, Lisonkova S, et al. Association between maternal chronic conditions and
congenital
heart defects: a population-based cohort study. Circulation 2013; 128:583.
19. Rosano A, Botto LD, Botting B, Mastroiacovo P. Infant mortality and congenital anomalies
from 1950 to 1994: an international perspective. J Epidemiol Community Health 2000; 54:660.
20. Boneva RS, Botto LD, Moore CA, et al. Mortality associated with congenital heart defects in
the United
States: trends and racial disparities, 1979-1997. Circulation 2001; 103:2376.
21. Hoffman JI. It is time for routine neonatal screening by pulse oximetry. Neonatology 2011;
99:1.
22. Schultz AH, Localio AR, Clark BJ, et al. Epidemiologic features of the presentation of critical
congenital
heart disease: implications for screening. Pediatrics 2008; 121:751.
23. Chang RK, Gurvitz M, Rodriguez S. Missed diagnosis of critical congenital heart disease.
Arch Pediatr
Adolesc Med 2008; 162:969.
24. Danford DA, McNamara DG. Infants with congenital heart disease in the first year of life. In:
The Science
and Practice of Pediatric Cardiology, Garson A, Bricker JT, Fisher DJ, Neish SR (Eds), Williams
&
Wilkins, Baltimore 1998. p.2228.
25. Pickert CB, Moss MM, Fiser DH. Differentiation of systemic infection and congenital
obstructive left heart
disease in the very young infant. Pediatr Emerg Care 1998; 14:263.
26. Ward KE, Mullins CE. Anomalous pulmonary venous connections, pulmonary vein stenosis,
and atresia
of the common pulmonary vein. In: The Science and Practice of Pediatric Cardiology, Garson A,
Bricker
JT, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.1445.
27. Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy:
implications for
routine examination. Arch Dis Child Fetal Neonatal Ed 1999; 80:F49.
28. de-Wahl Granelli A, Wennergren M, Sandberg K, et al. Impact of pulse oximetry screening on
the
detection of duct dependent congenital heart disease: a Swedish prospective screening study in
39,821
newborns. BMJ 2009; 338:a3037.
29. Oster ME, Riehle-Colarusso T, Alverson CJ, Correa A. Associations between maternal fever
and influenza
and congenital heart defects. J Pediatr 2011; 158:990.
30. Alverson CJ, Strickland MJ, Gilboa SM, Correa A. Maternal smoking and congenital heart
defects in the
Baltimore-Washington Infant Study. Pediatrics 2011; 127:e647.
31. Duff, FD, McNamara, DG. History and physical examination of the cardiovascular system. In:
The
Science and Practice of Pediatric Cardiology, Garson A, Bricker JT, Fisher DJ, Neish SR (Eds),
Williams
and Wilkins, Baltimore 1998. p.693.
32. Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to
lithium. JAMA
1994; 271:146.
33. Pinelli JM, Symington AJ, Cunningham KA, Paes BA. Case report and review of the perinatal
implications
of maternal lithium use. Am J Obstet Gynecol 2002; 187:245.
34. Lser H, Majewski F. Type and frequency of cardiac defects in embryofetal alcohol
syndrome. Report of
16 cases. Br Heart J 1977; 39:1374.
35. Tararbit K, Houyel L, Bonnet D, et al. Risk of congenital heart defects associated with
assisted
reproductive technologies: a population-based evaluation. Eur Heart J 2011; 32:500.
36. Romano-Zelekha O, Hirsh R, Blieden L, et al. The risk for congenital heart defects in
offspring of
individuals with congenital heart defects. Clin Genet 2001; 59:325.
37. Garson A. The electrocardiogram in infants and children: a systematic approach, Lea &
Febiger,
Philadelphia 1983.
38. Press S, Lipkind RS. Acute myocarditis in infants. Initial presentation. Clin Pediatr (Phila)
1990; 29:73.
39. Kimball TR, Daniels SR, Meyer RA, et al. Relation of symptoms to contractility and defect
size in infants
with ventricular septal defect. Am J Cardiol 1991; 67:1097.
40. Clark BJ 3rd. Treatment of heart failure in infants and children. Heart Dis 2000; 2:354.
41. Tanel RE, Rhodes LA. Fetal and neonatal arrhythmias. Clin Perinatol 2001; 28:187.
42. Perry JC. Supraventricular tachycardia. In: The Science and Practice of Pediatric Cardiology,
Garson A,
Bricker JT, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.2059.
43. Mehta AV. Rhabdomyoma and ventricular preexcitation syndrome. A report of two cases and
review of
literature. Am J Dis Child 1993; 147:669.
44. Trippel DL, Parsons MK, Gillette PC. Infants with long-QT syndrome and 2:1 atrioventricular
block. Am
Heart J 1995; 130:1130.
45. Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the
sudden infant
death syndrome. N Engl J Med 1998; 338:1709.
46. Towbin, JA, Greenberg, F. Genetic syndromes and clinical molecular genetics. In: The
Science and
Practice of Pediatric Cardiology, Garson A, Bricker JT, Fisher DJ, Neish SR (Eds), Williams and
Wilkins,
Baltimore 1998. p.2627.
47. Bonnet D, Martin D, Villain E, et al. Arrhythmias and conduction defects as presenting
symptoms of fatty
acid oxidation disorders in children. Circulation 1999; 100:2248.
48. Yabek SM. Neonatal cyanosis. Reappraisal of response to 100% oxygen breathing. Am J Dis
Child 1984;
138:880.
49. Rowe RD, et al. Abnormalities of the cardiovascular transition of the newborn: current views
on vascular
and myocardial responses. In: Pediatric Cardiology, Godman MJ (Ed), Churchill Livingstone,
New York
1981.
50. Kanarek KS, de Brigard T, Coleman J, Silbiger ML. Purulent pericarditis in a neonate. Pediatr
Infect Dis J
1991; 10:549.
51. El Hassan N, Dbaibo G, Diab K, et al. Pseudomonas pericarditis in an immunocompetent
newborn:
unusual presentation with review of the literature. J Infect 2002; 44:49.
52. White PH. Pediatric systemic lupus erythematosus and neonatal lupus. Rheum Dis Clin North
Am 1994;
20:119.
53. Abu-Harb M, Wyllie J, Hey E, et al. Presentation of obstructive left heart malformations in
infancy. Arch
Dis Child Fetal Neonatal Ed 1994; 71:F179.
54. Beebe SA, Britton JR, Britton HL, et al. Neonatal mortality and length of newborn hospital
stay. Pediatrics
1996; 98:231.
55. Ainsworth S, Wyllie JP, Wren C. Prevalence and clinical significance of cardiac murmurs in
neonates.
Arch Dis Child Fetal Neonatal Ed 1999; 80:F43.
56. Rein AJ, Omokhodion SI, Nir A. Significance of a cardiac murmur as the sole clinical sign in
the newborn.
Clin Pediatr (Phila) 2000; 39:511.
57. Arlettaz R, Archer N, Wilkinson AR. Natural history of innocent heart murmurs in newborn
babies:
controlled echocardiographic study. Arch Dis Child Fetal Neonatal Ed 1998; 78:F166.
58. Dunkle LM, Rowe RD. Transient murmur simulating pulmonary artery stenosis in premature
infants. Am J
Dis Child 1972; 124:666.
59. Danilowicz DA, Rudolph AM, Hoffman JI, Heymann M. Physiologic pressure differences
between main
and branch pulmonary arteries in infants. Circulation 1972; 45:410.
60. Rodriguez RJ, Riggs TW. Physiologic peripheral pulmonic stenosis in infancy. Am J Cardiol
1990;
66:1478.
61. Chatelain P, Oberhnsli I, Friedli B. Physiological pulmonary branch stenosis in newborns:
2Dechocardiographic
and Doppler characteristics and follow up. Eur J Pediatr 1993; 152:559.
62. Snider AR, Enderlein MA, Teitel DF, Juster RP. Two-dimensional echocardiographic
determination of
aortic and pulmonary artery sizes from infancy to adulthood in normal subjects. Am J Cardiol
1984;
53:218.
63. Hansen LK, Birkebaek NH, Oxhj H. Initial evaluation of children with heart murmurs by the
nonspecialized
paediatrician. Eur J Pediatr 1995; 154:15.
64. McCrindle BW, Shaffer KM, Kan JS, et al. Cardinal clinical signs in the differentiation of heart
murmurs in
children. Arch Pediatr Adolesc Med 1996; 150:169.
65. Smythe JF, Teixeira OH, Vlad P, et al. Initial evaluation of heart murmurs: are laboratory
tests necessary?
Pediatrics 1990; 86:497.
66. MCNAMARA DG. Prevention of infant deaths from congenital heart disease. Pediatr Clin
North Am 1963;
10:127.
67. Guignard JP, Gouyon JB, Adelman RD. Arterial hypertension in the newborn infant. Biol
Neonate 1989;
55:77.
68. Ing FF, Starc TJ, Griffiths SP, Gersony WM. Early diagnosis of coarctation of the aorta in
children: a
continuing dilemma. Pediatrics 1996; 98:378.
69. Lees MH. Cyanosis of the newborn infant. Recognition and clinical evaluation. J Pediatr
1970; 77:484.
Hoke TR, Donohue PK, Bawa PK, et al. Oxygen saturation as a screening test for critical
congenital heart
disease: a preliminary study. Pediatr Cardiol 2002; 23:403.
71. Moss AJ, McDonald LV. Cardiac disease in the wheezing child. Chest 1977; 71:187.
72. Ledwith MV, Duff DF. A review of vascular rings 1980-1992. Ir Med J 1994; 87:178.
73. Go RO, Martin TR, Lester MR. A wheezy infant unresponsive to bronchodilators. Ann Allergy
Asthma
Immunol 1997; 78:449.
74. Singer JI, Isaacman DJ, Bell LM. The wheezer that wasn't. Pediatr Emerg Care 1992; 8:107.
75. Pierpont ME, Basson CT, Benson DW Jr, et al. Genetic basis for congenital heart defects:
current
knowledge: a scientific statement from the American Heart Association Congenital Cardiac
Defects
Committee, Council on Cardiovascular Disease in the Young: endorsed by the American
Academy of
Pediatrics. Circulation 2007; 115:3015.
76. Hartman RJ, Rasmussen SA, Botto LD, et al. The contribution of chromosomal abnormalities
to
congenital heart defects: a population-based study. Pediatr Cardiol 2011; 32:1147.
77. Massin MM, Astadicko I, Dessy H. Noncardiac comorbidities of congenital heart disease in
children. Acta
Paediatr 2007; 96:753.
78. Meberg A, Brgmann-Pieper S, Due R Jr, et al. First day of life pulse oximetry screening to
detect
congenital heart defects. J Pediatr 2008; 152:761.
79. Riede FT, Wrner C, Dhnert I, et al. Effectiveness of neonatal pulse oximetry screening for
detection of
critical congenital heart disease in daily clinical routine--results from a prospective multicenter
study. Eur
J Pediatr 2010; 169:975.
80. Ewer AK, Middleton LJ, Furmston AT, et al. Pulse oximetry screening for congenital heart
defects in
newborn infants (PulseOx): a test accuracy study. Lancet 2011; 378:785.
81. Thangaratinam S, Brown K, Zamora J, et al. Pulse oximetry screening for critical congenital
heart defects
in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 2012;
379:2459.
82. Ewer AK, Furmston AT, Middleton LJ, et al. Pulse oximetry as a screening test for congenital
heart
defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-
effectiveness.
Health Technol Assess 2012; 16:v.
83. Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining
newborns for
congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics 2009;
124:823.
84. Valmari P. Should pulse oximetry be used to screen for congenital heart disease? Arch Dis
Child Fetal
Neonatal Ed 2007; 92:F219.
85. Richmond S, Reay G, Abu Harb M. Routine pulse oximetry in the asymptomatic newborn.
Arch Dis Child
Fetal Neonatal Ed 2002; 87:F83.
86. Koppel RI, Druschel CM, Carter T, et al. Effectiveness of pulse oximetry screening for
congenital heart
disease in asymptomatic newborns. Pediatrics 2003; 111:451.
87. Thangaratinam S, Daniels J, Ewer AK, et al. Accuracy of pulse oximetry in screening for
congenital heart
disease in asymptomatic newborns: a systematic review. Arch Dis Child Fetal Neonatal Ed 2007;
92:F176.
88. Poets CF, Stebbens VA. Detection of movement artifact in recorded pulse oximeter
saturation. Eur J
Pediatr 1997; 156:808.
89. Fouzas S, Priftis KN, Anthracopoulos MB. Pulse oximetry in pediatric practice. Pediatrics
2011; 128:740.
90. Reich JD, Connolly B, Bradley G, et al. Reliability of a single pulse oximetry reading as a
screening test
for congenital heart disease in otherwise asymptomatic newborn infants: the importance of
human factors.
Pediatr Cardiol 2008; 29:371.
91. Kemper AR, Mahle WT, Martin GR, et al. Strategies for implementing screening for critical
congenital
heart disease. Pediatrics 2011; 128:e1259.
92. Mahle WT, Martin GR, Beekman RH 3rd, et al. Endorsement of Health and Human Services
recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics
2012;
129:190.
93. Han LM, Klewer SE, Blank KM, et al. Feasibility of pulse oximetry screening for critical
congenital heart
disease at 2643-foot elevation. Pediatr Cardiol 2013; 34:1803.
2/10/2014 Congenital heart disease (CHD) in the newborn: Presentation and screening
Samuel TY, Bromiker R, Mimouni FB, et al. Newborn oxygen saturation at mild altitude versus
sea level:
implications for neonatal screening for critical congenital heart disease. Acta Paediatr 2013;
102:379.
95. Kochilas LK, Lohr JL, Bruhn E, et al. Implementation of critical congenital heart disease
screening in
Minnesota. Pediatrics 2013; 132:e587.
96. Peterson C, Grosse SD, Oster ME, et al. Cost-effectiveness of routine screening for critical
congenital
heart disease in US newborns. Pediatrics 2013; 132:e595.
97. Peterson C, Dawson A, Grosse SD, et al. Hospitalizations, costs, and mortality among infants
with
critical congenital heart disease: how important is timely detection? Birth Defects Res A Clin Mol
Teratol
2013; 97:664.
98. Martin GR, Beekman RH 3rd, Mikula EB, et al. Implementing recommended screening for
critical
congenital heart disease. Pediatrics 2013; 132:e185.
99. Garg LF, Van Naarden Braun K, Knapp MM, et al. Results from the New Jersey statewide
critical
congenital heart defects screening program. Pediatrics 2013; 132:e314.
100. Aisenberg RB, Rosenthal A, Nadas AS, Wolff PH. Developmental delay in infants with
congenital heart
disease. Correlation with hypoxemia and congestive heart failure. Pediatr Cardiol 1982; 3:133.

Ir Med J. 1994 Nov-Dec;87(6):178-9.
A review of vascular rings 1980-1992.
Ledwith MV, Duff DF.
Author information
Abstract
Over a period of 13 years 21 patients between the ages of three weeks and 13 years presenting to
this centre had a vascular ring. A double aortic arch was present in 11 cases, a right aortic arch with a
retroesophageal left subclavian artery in five cases, a right aortic arch with a normal left innominate
artery, a Kommerell's diverticulum and a left ligamentum arteriosum encircling the trachea and
oesophagus occurred in two cases and an aberrant left pulmonary artery arising from the right
pulmonary artery occurred in three cases. The majority (19/21) presented with a history of chronic
stridor, although other significant associated symptoms included: recurrent respiratory infection,
wheeze, cyanotic episodes and difficulty or pain on swallowing. The barium swallow was the most
useful method of investigation and was diagnostic in all of the 95% of cases in which it was
performed. Nineteen patients underwent surgery uneventfully although stridor often remained a
problem for some time following repair. Six patients (28%) had associated congenital heart disease.
Three (14%) patients who did not have surgery died.
PMID: 7860261 [PubMed - indexed for MEDLINE]
http://www.ncbi.nlm.nih.gov/pubmed/832490